Ciboy personal page - To The Moon

Ciboy

No personal profile

9Follow

1Followers

0Topic

0Badge

07-26

Great article, would you like to share it?

@hongg:$Tesla Motors(TSLA)$ a downgrade today. Will it go below 200 by EOW?

07-26

Great article, would you like to share it?

@SPACE ROCKET:I opened $CLSK 20240802 18.5 CALL$ ,Let's see how this goes. Wanted to sell 30 lots but Tiger has been crashing on me recently and not responding accurately to what I type. Kept registering 33 when I keyed in 30. So selling 33 it is!

07-26

Great article, would you like to share it?

@SPACE ROCKET:$CleanSpark, Inc.(CLSK)$ $Marathon Digital Holdings Inc(MARA)$ My trades are not behaving because of this 😵‍💫😵‍💫🤯🤯 I ended up selling funny number of lots because of wonky Tiger that keeps crashing. Samsung keeps asking me to put Tiger Brokers to deep sleep! 😴 💤 OMG 🤦‍♀️🤦‍♀️ @Barcode @nomadic_m @icycrystal

2021-09-11

Good buy?

Why Novavax Stock Slipped Thursday

2021-08-23

Thumbs up. Like please

Pfizer and BioNTech SE shares surged in premarket trading

2021-08-21

Good article

Sorry, the original content has been removed

2021-08-20

The 3 Rs.

2021-06-08

Like and comment

Sorry, the original content has been removed

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":3582794558746184,"uuid":"3582794558746184","gmtCreate":1619707409658,"gmtModify":1619707409658,"name":"Ciboy","pinyin":"ciboy","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":9,"tweetSize":10,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.01.25","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.04.06","exceedPercentage":"60.64%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":331534682796192,"gmtCreate":1721948669292,"gmtModify":1721948671255,"author":{"id":"3582794558746184","authorId":"3582794558746184","authorIdStr":"3582794558746184","name":"Ciboy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582794558746184"},"themes":[],"htmlText":"Great article, would you like to share it?","listText":"Great article, would you like to share it?","text":"Great article, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/331534682796192","repostId":"331365772005472","repostType":1,"repost":{"id":331365772005472,"gmtCreate":1721907793482,"gmtModify":1721907797135,"author":{"id":"3578638769183965","authorId":"3578638769183965","authorIdStr":"3578638769183965","name":"hongg","avatar":"https://static.tigerbbs.com/5a7a0b4bab6ad61e3bd4f1a19c4d1a03","crmLevel":8,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578638769183965"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/TSLA\">$Tesla Motors(TSLA)$&nbsp;</a><v-v data-views=\"0\"></v-v>&nbsp; a downgrade today. Will it go below 200 by EOW?","listText":"<a href=\"https://ttm.financial/S/TSLA\">$Tesla Motors(TSLA)$&nbsp;</a><v-v data-views=\"0\"></v-v>&nbsp; a downgrade today. Will it go below 200 by EOW?","text":"$Tesla Motors(TSLA)$ a downgrade today. Will it go below 200 by EOW?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/331365772005472","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":159,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":331534138331240,"gmtCreate":1721948660854,"gmtModify":1721948662841,"author":{"id":"3582794558746184","authorId":"3582794558746184","authorIdStr":"3582794558746184","name":"Ciboy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582794558746184"},"themes":[],"htmlText":"Great article, would you like to share it?","listText":"Great article, would you like to share it?","text":"Great article, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/331534138331240","repostId":"331398691086488","repostType":1,"repost":{"id":331398691086488,"gmtCreate":1721915434953,"gmtModify":1721977446441,"author":{"id":"4093561479903300","authorId":"4093561479903300","authorIdStr":"4093561479903300","name":"SPACE ROCKET","avatar":"https://community-static.tradeup.com/news/8d914d0fac29a13d969545b323fbfe8a","crmLevel":9,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4093561479903300"},"themes":[],"htmlText":"I opened <a href=\"https://ttm.financial/OPT/CLSK 20240802 18.5 CALL\">$CLSK 20240802 18.5 CALL$&nbsp;</a> ,Let's see how this goes. Wanted to sell 30 lots but Tiger has been crashing on me recently and not responding accurately to what I type. Kept registering 33 when I keyed in 30. So selling 33 it is!","listText":"I opened <a href=\"https://ttm.financial/OPT/CLSK 20240802 18.5 CALL\">$CLSK 20240802 18.5 CALL$&nbsp;</a> ,Let's see how this goes. Wanted to sell 30 lots but Tiger has been crashing on me recently and not responding accurately to what I type. Kept registering 33 when I keyed in 30. So selling 33 it is!","text":"I opened $CLSK 20240802 18.5 CALL$ ,Let's see how this goes. Wanted to sell 30 lots but Tiger has been crashing on me recently and not responding accurately to what I type. Kept registering 33 when I keyed in 30. So selling 33 it is!","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/331398691086488","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":48,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":331534055887072,"gmtCreate":1721948644797,"gmtModify":1721948648579,"author":{"id":"3582794558746184","authorId":"3582794558746184","authorIdStr":"3582794558746184","name":"Ciboy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582794558746184"},"themes":[],"htmlText":"Great article, would you like to share it?","listText":"Great article, would you like to share it?","text":"Great article, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/331534055887072","repostId":"331416561946720","repostType":1,"repost":{"id":331416561946720,"gmtCreate":1721920193370,"gmtModify":1721982707817,"author":{"id":"4093561479903300","authorId":"4093561479903300","authorIdStr":"4093561479903300","name":"SPACE ROCKET","avatar":"https://community-static.tradeup.com/news/8d914d0fac29a13d969545b323fbfe8a","crmLevel":9,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4093561479903300"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/CLSK\">$CleanSpark, Inc.(CLSK)$ </a>&nbsp;<a href=\"https://ttm.financial/S/MARA\">$Marathon Digital Holdings Inc(MARA)$ </a>&nbsp; My trades are not behaving because of this 😵‍💫😵‍💫🤯🤯 I ended up selling funny number of lots because of wonky Tiger that keeps crashing. Samsung keeps asking me to put Tiger Brokers to deep sleep! 😴 💤&nbsp;&nbsp;OMG&nbsp;🤦‍♀️🤦‍♀️ <a href=\"https://ttm.financial/U/4171900329979952\">@Barcode </a>&nbsp;<a href=\"https://ttm.financial/U/4142551860919612\">@nomadic_m </a>&nbsp;<a href=\"https://ttm.financial/U/4132300740238052\">@icycrystal </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/CLSK\">$CleanSpark, Inc.(CLSK)$ </a>&nbsp;<a href=\"https://ttm.financial/S/MARA\">$Marathon Digital Holdings Inc(MARA)$ </a>&nbsp; My trades are not behaving because of this 😵‍💫😵‍💫🤯🤯 I ended up selling funny number of lots because of wonky Tiger that keeps crashing. Samsung keeps asking me to put Tiger Brokers to deep sleep! 😴 💤&nbsp;&nbsp;OMG&nbsp;🤦‍♀️🤦‍♀️ <a href=\"https://ttm.financial/U/4171900329979952\">@Barcode </a>&nbsp;<a href=\"https://ttm.financial/U/4142551860919612\">@nomadic_m </a>&nbsp;<a href=\"https://ttm.financial/U/4132300740238052\">@icycrystal </a>&nbsp;","text":"$CleanSpark, Inc.(CLSK)$ $Marathon Digital Holdings Inc(MARA)$ My trades are not behaving because of this 😵‍💫😵‍💫🤯🤯 I ended up selling funny number of lots because of wonky Tiger that keeps crashing. Samsung keeps asking me to put Tiger Brokers to deep sleep! 😴 💤 OMG 🤦‍♀️🤦‍♀️ @Barcode @nomadic_m @icycrystal","images":[{"img":"https://community-static.tradeup.com/news/ed038a839300957d62869fb64c76e84a","width":"1440","height":"695"},{"img":"https://community-static.tradeup.com/news/af1f7492b9028567ec847cb80a851740","width":"1024","height":"1024"},{"img":"https://community-static.tradeup.com/news/feb091e9c1eb247badb3611373625d3f","width":"1024","height":"1024"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/331416561946720","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":3,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":98,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":881119079,"gmtCreate":1631316218291,"gmtModify":1676530525302,"author":{"id":"3582794558746184","authorId":"3582794558746184","authorIdStr":"3582794558746184","name":"Ciboy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582794558746184"},"themes":[],"htmlText":"Good buy?","listText":"Good buy?","text":"Good buy?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/881119079","repostId":"1158877090","repostType":4,"repost":{"id":"1158877090","pubTimestamp":1631259068,"share":"https://ttm.financial/m/news/1158877090?lang=&edition=fundamental","pubTime":"2021-09-10 15:31","market":"us","language":"en","title":"Why Novavax Stock Slipped Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=1158877090","media":"Motley Fool","summary":"(Update: Sept 10, 2021 at 04:14 a.m. ET)\n\nAuthorization of the company's COVID-19 vaccine in India a","content":"<p><i><b>(Update: Sept 10, 2021 at 04:14 a.m. ET)</b></i></p>\n<blockquote>\n <b>Authorization of the company's COVID-19 vaccine in India appears to have hit a speed bump.</b>\n</blockquote>\n<p><b>Key Points</b></p>\n<ul>\n <li>A report stated that the Indian government has requested additional data for Novavax's COVID-19 vaccine candidate before it can grant Emergency Use Authorization.</li>\n <li>EUA for the vaccine in India was originally expected in October but will now be pushed back.</li>\n <li>The delay isn't a huge blow for Novavax with the company's bigger opportunities in developed markets.</li>\n</ul>\n<p><b>What happened</b></p>\n<p>Shares of&nbsp;<b><a href=\"https://laohu8.com/S/NVAX\">Novavax</a></b> were slipping 2.6% lower as of 3:25 p.m. EDT on Thursday. The decline came following a report by&nbsp;<i>The Economic Times</i>&nbsp;that the Indian government has requested additional data from Novavax's partner, Serum Institute of India (SII), for COVID-19 vaccine candidate NVX-CoV2373 (which is called Covovax in India).</p>\n<p><b>So what</b></p>\n<p>SII filed for Emergency Use Authorization (EUA) in India for Covovax in August. This submission was based on data from international clinical studies. An official with the country's drug regulatory agency has asked for data from a clinical trial of the vaccine conducted in India, according to<i>The Economic Times</i>&nbsp;article.</p>\n<p>The problem is that SII likely won't be able to submit data from the clinical studies of Covovax in India until next month. SII CEO Adar Poonawalla stated in August that his organization hoped that the COVID-19 vaccine would be launched in India in October for adults and in the first quarter of 2022 for children. That timeline will now be pushed back.</p>\n<p>This delay isn't a huge blow for Novavax, as evidenced by the relatively small drop in thevaccine stock. The company's biggest opportunities are in developed markets including the U.S. and Europe.</p>\n<p><b>Now what</b></p>\n<p>Novavax expects to file for EUA for NVX-CoV2373 in the United Kingdom within the next few weeks. That filing should be quickly followed by submissions in Australia, New Zealand, and the European Union. The company remains on track to file for U.S. EUA in the fourth quarter of 2021.</p>\n<p>Novavax fell over 2% in premarket trading.</p>\n<p><img src=\"https://static.tigerbbs.com/d6cab4a5dd8795f7fda9bc597e6d9d98\" tg-width=\"996\" tg-height=\"568\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Novavax Stock Slipped Thursday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Novavax Stock Slipped Thursday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-10 15:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/09/why-novavax-stock-slipped-today/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Update: Sept 10, 2021 at 04:14 a.m. ET)\n\nAuthorization of the company's COVID-19 vaccine in India appears to have hit a speed bump.\n\nKey Points\n\nA report stated that the Indian government has ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/09/why-novavax-stock-slipped-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://www.fool.com/investing/2021/09/09/why-novavax-stock-slipped-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158877090","content_text":"(Update: Sept 10, 2021 at 04:14 a.m. ET)\n\nAuthorization of the company's COVID-19 vaccine in India appears to have hit a speed bump.\n\nKey Points\n\nA report stated that the Indian government has requested additional data for Novavax's COVID-19 vaccine candidate before it can grant Emergency Use Authorization.\nEUA for the vaccine in India was originally expected in October but will now be pushed back.\nThe delay isn't a huge blow for Novavax with the company's bigger opportunities in developed markets.\n\nWhat happened\nShares of Novavax were slipping 2.6% lower as of 3:25 p.m. EDT on Thursday. The decline came following a report by The Economic Times that the Indian government has requested additional data from Novavax's partner, Serum Institute of India (SII), for COVID-19 vaccine candidate NVX-CoV2373 (which is called Covovax in India).\nSo what\nSII filed for Emergency Use Authorization (EUA) in India for Covovax in August. This submission was based on data from international clinical studies. An official with the country's drug regulatory agency has asked for data from a clinical trial of the vaccine conducted in India, according toThe Economic Times article.\nThe problem is that SII likely won't be able to submit data from the clinical studies of Covovax in India until next month. SII CEO Adar Poonawalla stated in August that his organization hoped that the COVID-19 vaccine would be launched in India in October for adults and in the first quarter of 2022 for children. That timeline will now be pushed back.\nThis delay isn't a huge blow for Novavax, as evidenced by the relatively small drop in thevaccine stock. The company's biggest opportunities are in developed markets including the U.S. and Europe.\nNow what\nNovavax expects to file for EUA for NVX-CoV2373 in the United Kingdom within the next few weeks. That filing should be quickly followed by submissions in Australia, New Zealand, and the European Union. The company remains on track to file for U.S. EUA in the fourth quarter of 2021.\nNovavax fell over 2% in premarket trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":302,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":835841840,"gmtCreate":1629706755480,"gmtModify":1676530105833,"author":{"id":"3582794558746184","authorId":"3582794558746184","authorIdStr":"3582794558746184","name":"Ciboy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582794558746184"},"themes":[],"htmlText":"Thumbs up. Like please","listText":"Thumbs up. Like please","text":"Thumbs up. Like please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/835841840","repostId":"1104804215","repostType":4,"repost":{"id":"1104804215","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1629706373,"share":"https://ttm.financial/m/news/1104804215?lang=&edition=fundamental","pubTime":"2021-08-23 16:12","market":"us","language":"en","title":"Pfizer and BioNTech SE shares surged in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1104804215","media":"Tiger Newspress","summary":"Pfizer and BioNTech SE shares surged in premarket trading.The F.D.A. is aiming to give full approval","content":"<p>Pfizer and BioNTech SE shares surged in premarket trading.The F.D.A. is aiming to give full approval to Pfizer’s Covid vaccine on Monday,according to the New York Times.</p>\n<p><img src=\"https://static.tigerbbs.com/7fdc37e9193346a16038693153dd045e\" tg-width=\"362\" tg-height=\"125\" width=\"100%\" height=\"auto\"></p>\n<p>The Food and Drug Administration is pushing to approve Pfizer-BioNTech’s two-dose Covid-19 vaccine on Monday, further expediting an earlier timeline for licensing the shot, according to people familiar with the agency’s planning.</p>\n<p>Regulators were working to finish the process by Friday but were still working through a substantial amount of paperwork and negotiation with the company. The people familiar with the planning, who were not authorized to speak publicly about it, cautioned that the approval might slide beyond Monday if some components of the review need more time.</p>\n<p>An F.D.A. spokeswoman declined to comment.</p>\n<p>The agency had recently set an unofficial deadline for approval of around Labor Day.</p>\n<p>The approval is expected to pave the way for a series of vaccination requirements by public and private organizations who were awaiting final regulatory action before putting in effect mandates. Federal and state health officials are also hoping that an approved vaccine will draw interest from some Americans who have been hesitant to take one that was only authorized for emergency use, a phenomenon suggested by recent polling.</p>\n<p>Some universities and hospitals are expected to mandate inoculation once a vaccine is fully approved. The Pentagon this month&nbsp;said it planned&nbsp;to make Covid vaccinations mandatory for the country’s 1.3 million active-duty troops “no later” than the middle of next month, or sooner if the F.D.A. acts earlier.</p>\n<p>Once it obtains the approval, Pfizer-BioNTech is planning to quickly ask the F.D.A. to approve a third dose as a booster shot. The Biden administration on Wednesday announced that fully vaccinated adults should prepare to get booster shots eight months after they received their second doses, beginning Sept. 20. Pfizer is expected to finish submitting data that it says shows a third shot is safe and effective next week.</p>\n<p>The F.D.A. last week updated its authorizations of Pfizer-BioNTech’s and Moderna’s vaccines to allow third doses for some immunocompromised people, a decision backed by the Centers for Disease Control and Prevention.</p>\n<p>Regulators are still reviewing Moderna’s application for full approval for its coronavirus vaccine, and a decision could come at least several weeks after the one for Pfizer-BioNTech. Moderna is planning to submit its data in support of a booster shot in September.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer and BioNTech SE shares surged in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer and BioNTech SE shares surged in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-23 16:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Pfizer and BioNTech SE shares surged in premarket trading.The F.D.A. is aiming to give full approval to Pfizer’s Covid vaccine on Monday,according to the New York Times.</p>\n<p><img src=\"https://static.tigerbbs.com/7fdc37e9193346a16038693153dd045e\" tg-width=\"362\" tg-height=\"125\" width=\"100%\" height=\"auto\"></p>\n<p>The Food and Drug Administration is pushing to approve Pfizer-BioNTech’s two-dose Covid-19 vaccine on Monday, further expediting an earlier timeline for licensing the shot, according to people familiar with the agency’s planning.</p>\n<p>Regulators were working to finish the process by Friday but were still working through a substantial amount of paperwork and negotiation with the company. The people familiar with the planning, who were not authorized to speak publicly about it, cautioned that the approval might slide beyond Monday if some components of the review need more time.</p>\n<p>An F.D.A. spokeswoman declined to comment.</p>\n<p>The agency had recently set an unofficial deadline for approval of around Labor Day.</p>\n<p>The approval is expected to pave the way for a series of vaccination requirements by public and private organizations who were awaiting final regulatory action before putting in effect mandates. Federal and state health officials are also hoping that an approved vaccine will draw interest from some Americans who have been hesitant to take one that was only authorized for emergency use, a phenomenon suggested by recent polling.</p>\n<p>Some universities and hospitals are expected to mandate inoculation once a vaccine is fully approved. The Pentagon this month&nbsp;said it planned&nbsp;to make Covid vaccinations mandatory for the country’s 1.3 million active-duty troops “no later” than the middle of next month, or sooner if the F.D.A. acts earlier.</p>\n<p>Once it obtains the approval, Pfizer-BioNTech is planning to quickly ask the F.D.A. to approve a third dose as a booster shot. The Biden administration on Wednesday announced that fully vaccinated adults should prepare to get booster shots eight months after they received their second doses, beginning Sept. 20. Pfizer is expected to finish submitting data that it says shows a third shot is safe and effective next week.</p>\n<p>The F.D.A. last week updated its authorizations of Pfizer-BioNTech’s and Moderna’s vaccines to allow third doses for some immunocompromised people, a decision backed by the Centers for Disease Control and Prevention.</p>\n<p>Regulators are still reviewing Moderna’s application for full approval for its coronavirus vaccine, and a decision could come at least several weeks after the one for Pfizer-BioNTech. Moderna is planning to submit its data in support of a booster shot in September.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1104804215","content_text":"Pfizer and BioNTech SE shares surged in premarket trading.The F.D.A. is aiming to give full approval to Pfizer’s Covid vaccine on Monday,according to the New York Times.\n\nThe Food and Drug Administration is pushing to approve Pfizer-BioNTech’s two-dose Covid-19 vaccine on Monday, further expediting an earlier timeline for licensing the shot, according to people familiar with the agency’s planning.\nRegulators were working to finish the process by Friday but were still working through a substantial amount of paperwork and negotiation with the company. The people familiar with the planning, who were not authorized to speak publicly about it, cautioned that the approval might slide beyond Monday if some components of the review need more time.\nAn F.D.A. spokeswoman declined to comment.\nThe agency had recently set an unofficial deadline for approval of around Labor Day.\nThe approval is expected to pave the way for a series of vaccination requirements by public and private organizations who were awaiting final regulatory action before putting in effect mandates. Federal and state health officials are also hoping that an approved vaccine will draw interest from some Americans who have been hesitant to take one that was only authorized for emergency use, a phenomenon suggested by recent polling.\nSome universities and hospitals are expected to mandate inoculation once a vaccine is fully approved. The Pentagon this month said it planned to make Covid vaccinations mandatory for the country’s 1.3 million active-duty troops “no later” than the middle of next month, or sooner if the F.D.A. acts earlier.\nOnce it obtains the approval, Pfizer-BioNTech is planning to quickly ask the F.D.A. to approve a third dose as a booster shot. The Biden administration on Wednesday announced that fully vaccinated adults should prepare to get booster shots eight months after they received their second doses, beginning Sept. 20. Pfizer is expected to finish submitting data that it says shows a third shot is safe and effective next week.\nThe F.D.A. last week updated its authorizations of Pfizer-BioNTech’s and Moderna’s vaccines to allow third doses for some immunocompromised people, a decision backed by the Centers for Disease Control and Prevention.\nRegulators are still reviewing Moderna’s application for full approval for its coronavirus vaccine, and a decision could come at least several weeks after the one for Pfizer-BioNTech. Moderna is planning to submit its data in support of a booster shot in September.","news_type":1},"isVote":1,"tweetType":1,"viewCount":438,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":836511851,"gmtCreate":1629506796773,"gmtModify":1676530060186,"author":{"id":"3582794558746184","authorId":"3582794558746184","authorIdStr":"3582794558746184","name":"Ciboy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582794558746184"},"themes":[],"htmlText":"Good article","listText":"Good article","text":"Good article","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/836511851","repostId":"2160176501","repostType":4,"isVote":1,"tweetType":1,"viewCount":136,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":838259531,"gmtCreate":1629415328623,"gmtModify":1676530031024,"author":{"id":"3582794558746184","authorId":"3582794558746184","authorIdStr":"3582794558746184","name":"Ciboy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582794558746184"},"themes":[],"htmlText":"The 3 Rs.","listText":"The 3 Rs.","text":"The 3 Rs.","images":[{"img":"https://static.tigerbbs.com/2b73a296bec84f92723b409fc422943f","width":"1440","height":"1835"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/838259531","isVote":1,"tweetType":1,"viewCount":151,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":114747983,"gmtCreate":1623108223142,"gmtModify":1704196056249,"author":{"id":"3582794558746184","authorId":"3582794558746184","authorIdStr":"3582794558746184","name":"Ciboy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582794558746184"},"themes":[],"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/114747983","repostId":"2141342255","repostType":4,"isVote":1,"tweetType":1,"viewCount":208,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":114747983,"gmtCreate":1623108223142,"gmtModify":1704196056249,"author":{"id":"3582794558746184","authorId":"3582794558746184","authorIdStr":"3582794558746184","name":"Ciboy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582794558746184"},"themes":[],"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/114747983","repostId":"2141342255","repostType":4,"repost":{"id":"2141342255","pubTimestamp":1623098661,"share":"https://ttm.financial/m/news/2141342255?lang=&edition=fundamental","pubTime":"2021-06-08 04:44","market":"us","language":"en","title":"S&P closes nominally lower as investors wait for a catalyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2141342255","media":"REUTERS","summary":"NEW YORK (REUTERS) - The S&P 500 ended a languid session slightly in the red on Monday (June 7), wit","content":"<div>\n<p>NEW YORK (REUTERS) - The S&P 500 ended a languid session slightly in the red on Monday (June 7), with investors standing by on news of a global minimum corporate tax rate, lingering inflation fears, ...</p>\n\n<a href=\"http://www.straitstimes.com/business/companies-markets/sp-closes-nominally-lower-as-investors-wait-for-a-catalyst\">Web Link</a>\n\n</div>\n","source":"straits_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P closes nominally lower as investors wait for a catalyst</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P closes nominally lower as investors wait for a catalyst\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-08 04:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://www.straitstimes.com/business/companies-markets/sp-closes-nominally-lower-as-investors-wait-for-a-catalyst><strong>REUTERS</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>NEW YORK (REUTERS) - The S&P 500 ended a languid session slightly in the red on Monday (June 7), with investors standing by on news of a global minimum corporate tax rate, lingering inflation fears, ...</p>\n\n<a href=\"http://www.straitstimes.com/business/companies-markets/sp-closes-nominally-lower-as-investors-wait-for-a-catalyst\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OEX":"标普100",".SPX":"S&P 500 Index","SH":"标普500反向ETF","OEF":"标普100指数ETF-iShares","SSO":"两倍做多标普500ETF","IVV":"标普500指数ETF","UPRO":"三倍做多标普500ETF","BIIB":"渤健公司","SPXU":"三倍做空标普500ETF","SDS":"两倍做空标普500ETF"},"source_url":"http://www.straitstimes.com/business/companies-markets/sp-closes-nominally-lower-as-investors-wait-for-a-catalyst","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2141342255","content_text":"NEW YORK (REUTERS) - The S&P 500 ended a languid session slightly in the red on Monday (June 7), with investors standing by on news of a global minimum corporate tax rate, lingering inflation fears, and a lack of market-moving economic news.The Dow closed well within negative territory, while the Nasdaq advanced. Still, the S&P and the Dow remained inside one percentage point of their record closing highs.\"Thematically, we're done with earnings, so you have this lull in between earnings when what drives the market is economic data points,\" said Joseph Sroka, chief investment officer at NovaPoint in Atlanta. \"There's not a lot of impetus for investors to take action today.\"\"There's been this flip-flop between whether inflation will be transitory or persistent, and the next card that gets flipped over for that is the CPI report on Thursday,\" Sroka added.Small-caps outperformed as the ongoing retail frenzy boosted stocks whose recent explosive trading volumes have been attributed to social media buzz.AMC Entertainment Holdings jumped 14.8%, extending the previous week's 85% gain.Other so-called \"meme stocks,\" including GameStop and US-listed shares of Blackberry advanced between 7% and 14%.\"You've seen a decades-long, technology-enabled democratisation of the market and there's certainly groups of individual investors that flock to these ideas,\" Sroka said. \"We're seeing speculative trading in an age of multiple outlets and social media amplifies the news.\"The Group of Seven (G-7) advanced economies agreed on Saturday to back a minimum global corporate tax rate of at least 15%, a move Treasury Secretary Janet Yellen called a \"significant, unprecedented commitment\" to bring what she called a race to the bottom on global taxation.Lawmakers in Washington are doubling down on efforts to craft a bipartisan infrastructure spending package, with House Democrats expected to bring a bill to vote as early as Wednesday.The Dow Jones Industrial Average fell 126.15 points, or 0.36%, to 34,630.24; the S&P 500 lost 3.37 points, or 0.08%, at 4,226.52; and the Nasdaq Composite added 67.23 points, or 0.49%, at 13,881.72.Of the 11 major sectors in the S&P 500, seven lost ground, with materials suffering the largest percentage drop.Real estate led the gainers.Shares of Biogen Inc surged 38.3% following news that the US Food and Drug Administration approved its Alzheimer's disease drug aducanumab.Data centre operator QTS Realty Trust jumped 21.2% on reports of a takeover deal by investment firm Blackstone Group worth $6.7 billion. Cruise operator Royal Caribbean announced that six of its ships would begin sailing from Florida and Texas ports in July and August.Its shares gained 0.4%, while rivals Carnival and Norwegian Cruise Line advanced 1.1% and 3.1%, respectively.Advancing issues outnumbered decliners on the NYSE by a 1.35-to-1 ratio; on Nasdaq, a 1.82-to-1 ratio favored advancers.The S&P 500 posted 62 new 52-week highs and one new low; the Nasdaq Composite recorded 168 new highs and 21 new lows.Volume on U.S. exchanges was 10.52 billion shares, compared with the 10.71 billion average over the last 20 trading days.","news_type":1},"isVote":1,"tweetType":1,"viewCount":208,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":835841840,"gmtCreate":1629706755480,"gmtModify":1676530105833,"author":{"id":"3582794558746184","authorId":"3582794558746184","authorIdStr":"3582794558746184","name":"Ciboy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582794558746184"},"themes":[],"htmlText":"Thumbs up. Like please","listText":"Thumbs up. Like please","text":"Thumbs up. Like please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/835841840","repostId":"1104804215","repostType":4,"isVote":1,"tweetType":1,"viewCount":438,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":881119079,"gmtCreate":1631316218291,"gmtModify":1676530525302,"author":{"id":"3582794558746184","authorId":"3582794558746184","authorIdStr":"3582794558746184","name":"Ciboy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582794558746184"},"themes":[],"htmlText":"Good buy?","listText":"Good buy?","text":"Good buy?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/881119079","repostId":"1158877090","repostType":4,"isVote":1,"tweetType":1,"viewCount":302,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":836511851,"gmtCreate":1629506796773,"gmtModify":1676530060186,"author":{"id":"3582794558746184","authorId":"3582794558746184","authorIdStr":"3582794558746184","name":"Ciboy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582794558746184"},"themes":[],"htmlText":"Good article","listText":"Good article","text":"Good article","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/836511851","repostId":"2160176501","repostType":4,"repost":{"id":"2160176501","pubTimestamp":1629372900,"share":"https://ttm.financial/m/news/2160176501?lang=&edition=fundamental","pubTime":"2021-08-19 19:35","market":"us","language":"en","title":"5 Ultra-Popular Stocks With 108% to 212% Upside, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2160176501","media":"Motley Fool","summary":"At least a handful of Wall Street analysts and investment banks expect these widely followed stocks to soar.","content":"<p>Time and again, investors have learned the power of patience on Wall Street. Despite the benchmark <b>S&amp;P 500</b> losing 34% of its value in roughly a <a href=\"https://laohu8.com/S/AONE.U\">one</a>-month stretch during the first quarter of 2020, the index has completely erased its decline and effectively doubled in value since finding a bottom.</p>\n<p>What you might find surprising is that, according to some analysts and investment banks on Wall Street, the upside for certain stocks isn't anywhere near complete. Based on the highest issued price target from Wall Street for the following five ultra-popular stocks, investors could double, or even triple, their money.</p>\n<p><img src=\"https://static.tigerbbs.com/8cf8fd6cbc9120f885acecdfb00d5835\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3>Nio: Implied upside of 125%</h3>\n<p>The first extremely popular stock investors can't stop eyeing or buying that has a lofty price target applied by Wall Street is China-based electric-vehicle (EV) manufacturer <b>Nio</b> (NYSE:NIO). With a currency-converted top-end target of about $92 a share, Nio could drive investors to a 125% return, if this price target proves accurate.</p>\n<p>The Nio growth story has both macro and micro tailwinds. On a macro basis, China is the largest auto market in the world, and is therefore the top opportunity for auto stocks to benefit from a multi-decade vehicle replacement shift to EVs. With the country's EV industry still nascent, there's plenty of market share up for grabs.</p>\n<p>On a company-specific basis, Nio has built up an impressive cash hoard and has demonstrated that it can ramp up production. Even with a global chip shortage, Nio delivered almost 21,900 EVs in the second quarter.&nbsp; It looks to be well on its way to producing an annual run-rate of 150,000 EVs, once chip supply issues are resolved.</p>\n<p>What's more, Nio introduced its battery-as-a-service program last year, which should improve customer loyalty and trade some near-term revenue for higher long-term operating margins.</p>\n<p>Although $92 a share is a bit aggressive for a company that's only delivered around 125,500 EVs since its inception, Nio's growth trajectory is certainly headed in the right direction.</p>\n<p><img src=\"https://static.tigerbbs.com/bc514068ded899a817770f684369db36\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3>Canopy Growth: Implied upside of 126%</h3>\n<p>Another ultra-popular company that at least one Wall Street firm remains very bullish on is Canadian marijuana stock <b>Canopy Growth</b> (NASDAQ:CGC). If the loftiest price target of 51 Canadian dollars ($40.70 U.S.) were to become a reality, Canopy Growth would rocket higher by 126%.</p>\n<p>The optimism surrounding the company probably has to do with its leading market share in the Canadian weed industry, as well as its massive cash war chest. According to the company, it maintained a 15.2% share of weed sales in tracked provinces in the calendar second quarter.&nbsp; That's an impressive figure given how competitive the Canadian cannabis landscape has become over the past three years.</p>\n<p>Furthermore, Canopy Growth ended June with CA$2.05 billion in cash and cash equivalents, which means it has more than enough capital to continue executing on its strategy. If you're wondering why it's so flush with cash, look no further than multiple direct equity investments from spirits giant <b>Constellation Brands</b>.</p>\n<p>However -- and this is a big \"however\" -- the Canadian pot industry and Canopy Growth have been an utter disaster since marijuana was legalized in October 2018. Canadian regulators threw cold water on the industry by delaying cultivation and sales license applications. Meanwhile, Canopy Growth did itself no favors by over-expanding its production capacity and grossly overpaying for acquisitions. The bottom line is that Canopy Growth has burned through close to CA$3 billion in cash in less than three years, which makes a CA$51 price target highly unlikely.</p>\n<p><img src=\"https://static.tigerbbs.com/0d4100110a4b55276a039eb89efa6151\" tg-width=\"700\" tg-height=\"465\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3>Penn National Gaming: Implied upside of 113%</h3>\n<p>Wall Street also appears to be rolling the dice on gaming and sports betting company <b>Penn National Gaming</b> (NASDAQ:PENN). The highest Wall Street price target forecasts that Penn National will head to $151 a share, which would represent a cool 113% return from where it closed the previous week.</p>\n<p>Penn's overwhelming success since the pandemic struck can be tied to two key factors. First, it owns 43 gaming or horse-racing properties in 20 states. Whereas most casinos were pulverized by the pandemic, Penn National escaped much of this pain since its properties aren't located solely in tourist destinations. In other words, Penn's gaming properties encourage local foot traffic, which is one reason it's so successful.</p>\n<p>Arguably the bigger reason Penn has been on fire since the pandemic began is the 36% equity stake it took in online sports-betting service Barstool Sports in February 2020. With people staying home due to the pandemic, some turned to online sports wagering and fantasy sports betting for entertainment.</p>\n<p>With online sports betting offering sustainable double-digit growth potential, and Penn National's gaming properties well-insulated from the turmoil hitting regions like Las Vegas and Macao, it has a reasonable chance to eventually hit Wall Street's loftiest price target.</p>\n<p><img src=\"https://static.tigerbbs.com/16ca48e46c5ed915bdfaeb115d44e553\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3>JD.com: Implied upside of 108%</h3>\n<p>At least one Wall Street analyst is buying into the <b>JD.com</b> (NASDAQ:JD) growth story. Even with Chinese regulators cracking down on domestic tech companies, the highest price target on Wall Street implies up to 108% upside for China's second-largest e-commerce stock.</p>\n<p>Perhaps one reason analysts feel so comfortable with JD is the company's markedly different operating model from <b>Alibaba</b>, China's leading e-commerce company. Alibaba primarily operates as a third-party online marketplace, and was hit with a record $2.8 billion antitrust fine from Chinese regulators this past April.</p>\n<p>Meanwhile, JD almost exclusively sells goods directly to Chinese consumers. This means it operates an <b>Amazon</b>-like business model, whereby it controls its inventory and logistics. This makes it far less likely that JD falls under the microscope of Chinese regulators.</p>\n<p>The great thing about JD is that it's expanded its reach beyond just e-commerce. More specifically, it's generating revenue from advertising, healthcare services, and cloud services. The latter is particularly intriguing given that cloud margins are substantially higher than online retail margins. Though these ancillary services only accounted for 14% of the company's total sales in the first quarter, services revenue skyrocketed 73%.</p>\n<p>While the near term could remain uncertain for JD, it has a solid foundation in place to eventually double shareholders' money.</p>\n<p><img src=\"https://static.tigerbbs.com/51b9e73cc74dad844548f15906c23624\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3>Plug Power: Implied upside of 212%</h3>\n<p>The final ultra-popular stock that Wall Street believes has incredible upside is hydrogen fuel-cell solutions provider <b>Plug Power</b> (NASDAQ:PLUG). Based on the most aggressive price target of $78, Plug Power could climb 212%, compared to where it closed last week ($24.99).</p>\n<p>The bull thesis for Plug Power is very similar to that of Nio. Namely, we're witnessing a shift away from combustion-engine vehicles and toward green energy-powered vehicles. This shift won't happen overnight, but will instead provide a multi-decade opportunity for consumers and businesses to make the shift.</p>\n<p>Plug Power really excited investors in January when the company forged two significant joint ventures just a few days apart. First, SK Group took a 10% equity stake in Plug Power, with the intent of working with Plug to bring hydrogen fuel-cell-powered cars and refilling stations to South Korea. Days later, Plug linked up with French automaker <b>Renault</b> to launch Hyvia, which'll target Europe's light commercial vehicle market.</p>\n<p>At this point, there's little doubt that Plug Power's sales growth will impress for years to come. Between 2020 and 2024, the company anticipates growing its gross billings from $337 million to about $1.7 billion. The real question is whether investors can support a large valuation without profits. Until Plug Power makes the turn to recurring profitability, a $78 price target is probably out of the question.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Ultra-Popular Stocks With 108% to 212% Upside, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Ultra-Popular Stocks With 108% to 212% Upside, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-19 19:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/19/5-ultra-popular-stocks-with-108-to-212-upside/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Time and again, investors have learned the power of patience on Wall Street. Despite the benchmark S&P 500 losing 34% of its value in roughly a one-month stretch during the first quarter of 2020, the ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/19/5-ultra-popular-stocks-with-108-to-212-upside/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JD":"京东","PLUG":"普拉格能源","09618":"京东集团-SW","NIO":"蔚来"},"source_url":"https://www.fool.com/investing/2021/08/19/5-ultra-popular-stocks-with-108-to-212-upside/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2160176501","content_text":"Time and again, investors have learned the power of patience on Wall Street. Despite the benchmark S&P 500 losing 34% of its value in roughly a one-month stretch during the first quarter of 2020, the index has completely erased its decline and effectively doubled in value since finding a bottom.\nWhat you might find surprising is that, according to some analysts and investment banks on Wall Street, the upside for certain stocks isn't anywhere near complete. Based on the highest issued price target from Wall Street for the following five ultra-popular stocks, investors could double, or even triple, their money.\n\nImage source: Getty Images.\nNio: Implied upside of 125%\nThe first extremely popular stock investors can't stop eyeing or buying that has a lofty price target applied by Wall Street is China-based electric-vehicle (EV) manufacturer Nio (NYSE:NIO). With a currency-converted top-end target of about $92 a share, Nio could drive investors to a 125% return, if this price target proves accurate.\nThe Nio growth story has both macro and micro tailwinds. On a macro basis, China is the largest auto market in the world, and is therefore the top opportunity for auto stocks to benefit from a multi-decade vehicle replacement shift to EVs. With the country's EV industry still nascent, there's plenty of market share up for grabs.\nOn a company-specific basis, Nio has built up an impressive cash hoard and has demonstrated that it can ramp up production. Even with a global chip shortage, Nio delivered almost 21,900 EVs in the second quarter.  It looks to be well on its way to producing an annual run-rate of 150,000 EVs, once chip supply issues are resolved.\nWhat's more, Nio introduced its battery-as-a-service program last year, which should improve customer loyalty and trade some near-term revenue for higher long-term operating margins.\nAlthough $92 a share is a bit aggressive for a company that's only delivered around 125,500 EVs since its inception, Nio's growth trajectory is certainly headed in the right direction.\n\nImage source: Getty Images.\nCanopy Growth: Implied upside of 126%\nAnother ultra-popular company that at least one Wall Street firm remains very bullish on is Canadian marijuana stock Canopy Growth (NASDAQ:CGC). If the loftiest price target of 51 Canadian dollars ($40.70 U.S.) were to become a reality, Canopy Growth would rocket higher by 126%.\nThe optimism surrounding the company probably has to do with its leading market share in the Canadian weed industry, as well as its massive cash war chest. According to the company, it maintained a 15.2% share of weed sales in tracked provinces in the calendar second quarter.  That's an impressive figure given how competitive the Canadian cannabis landscape has become over the past three years.\nFurthermore, Canopy Growth ended June with CA$2.05 billion in cash and cash equivalents, which means it has more than enough capital to continue executing on its strategy. If you're wondering why it's so flush with cash, look no further than multiple direct equity investments from spirits giant Constellation Brands.\nHowever -- and this is a big \"however\" -- the Canadian pot industry and Canopy Growth have been an utter disaster since marijuana was legalized in October 2018. Canadian regulators threw cold water on the industry by delaying cultivation and sales license applications. Meanwhile, Canopy Growth did itself no favors by over-expanding its production capacity and grossly overpaying for acquisitions. The bottom line is that Canopy Growth has burned through close to CA$3 billion in cash in less than three years, which makes a CA$51 price target highly unlikely.\n\nImage source: Getty Images.\nPenn National Gaming: Implied upside of 113%\nWall Street also appears to be rolling the dice on gaming and sports betting company Penn National Gaming (NASDAQ:PENN). The highest Wall Street price target forecasts that Penn National will head to $151 a share, which would represent a cool 113% return from where it closed the previous week.\nPenn's overwhelming success since the pandemic struck can be tied to two key factors. First, it owns 43 gaming or horse-racing properties in 20 states. Whereas most casinos were pulverized by the pandemic, Penn National escaped much of this pain since its properties aren't located solely in tourist destinations. In other words, Penn's gaming properties encourage local foot traffic, which is one reason it's so successful.\nArguably the bigger reason Penn has been on fire since the pandemic began is the 36% equity stake it took in online sports-betting service Barstool Sports in February 2020. With people staying home due to the pandemic, some turned to online sports wagering and fantasy sports betting for entertainment.\nWith online sports betting offering sustainable double-digit growth potential, and Penn National's gaming properties well-insulated from the turmoil hitting regions like Las Vegas and Macao, it has a reasonable chance to eventually hit Wall Street's loftiest price target.\n\nImage source: Getty Images.\nJD.com: Implied upside of 108%\nAt least one Wall Street analyst is buying into the JD.com (NASDAQ:JD) growth story. Even with Chinese regulators cracking down on domestic tech companies, the highest price target on Wall Street implies up to 108% upside for China's second-largest e-commerce stock.\nPerhaps one reason analysts feel so comfortable with JD is the company's markedly different operating model from Alibaba, China's leading e-commerce company. Alibaba primarily operates as a third-party online marketplace, and was hit with a record $2.8 billion antitrust fine from Chinese regulators this past April.\nMeanwhile, JD almost exclusively sells goods directly to Chinese consumers. This means it operates an Amazon-like business model, whereby it controls its inventory and logistics. This makes it far less likely that JD falls under the microscope of Chinese regulators.\nThe great thing about JD is that it's expanded its reach beyond just e-commerce. More specifically, it's generating revenue from advertising, healthcare services, and cloud services. The latter is particularly intriguing given that cloud margins are substantially higher than online retail margins. Though these ancillary services only accounted for 14% of the company's total sales in the first quarter, services revenue skyrocketed 73%.\nWhile the near term could remain uncertain for JD, it has a solid foundation in place to eventually double shareholders' money.\n\nImage source: Getty Images.\nPlug Power: Implied upside of 212%\nThe final ultra-popular stock that Wall Street believes has incredible upside is hydrogen fuel-cell solutions provider Plug Power (NASDAQ:PLUG). Based on the most aggressive price target of $78, Plug Power could climb 212%, compared to where it closed last week ($24.99).\nThe bull thesis for Plug Power is very similar to that of Nio. Namely, we're witnessing a shift away from combustion-engine vehicles and toward green energy-powered vehicles. This shift won't happen overnight, but will instead provide a multi-decade opportunity for consumers and businesses to make the shift.\nPlug Power really excited investors in January when the company forged two significant joint ventures just a few days apart. First, SK Group took a 10% equity stake in Plug Power, with the intent of working with Plug to bring hydrogen fuel-cell-powered cars and refilling stations to South Korea. Days later, Plug linked up with French automaker Renault to launch Hyvia, which'll target Europe's light commercial vehicle market.\nAt this point, there's little doubt that Plug Power's sales growth will impress for years to come. Between 2020 and 2024, the company anticipates growing its gross billings from $337 million to about $1.7 billion. The real question is whether investors can support a large valuation without profits. Until Plug Power makes the turn to recurring profitability, a $78 price target is probably out of the question.","news_type":1},"isVote":1,"tweetType":1,"viewCount":136,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":331534682796192,"gmtCreate":1721948669292,"gmtModify":1721948671255,"author":{"id":"3582794558746184","authorId":"3582794558746184","authorIdStr":"3582794558746184","name":"Ciboy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582794558746184"},"themes":[],"htmlText":"Great article, would you like to share it?","listText":"Great article, would you like to share it?","text":"Great article, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/331534682796192","repostId":"331365772005472","repostType":1,"repost":{"id":331365772005472,"gmtCreate":1721907793482,"gmtModify":1721907797135,"author":{"id":"3578638769183965","authorId":"3578638769183965","authorIdStr":"3578638769183965","name":"hongg","avatar":"https://static.tigerbbs.com/5a7a0b4bab6ad61e3bd4f1a19c4d1a03","crmLevel":8,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578638769183965"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/TSLA\">$Tesla Motors(TSLA)$&nbsp;</a><v-v data-views=\"0\"></v-v>&nbsp; a downgrade today. Will it go below 200 by EOW?","listText":"<a href=\"https://ttm.financial/S/TSLA\">$Tesla Motors(TSLA)$&nbsp;</a><v-v data-views=\"0\"></v-v>&nbsp; a downgrade today. Will it go below 200 by EOW?","text":"$Tesla Motors(TSLA)$ a downgrade today. Will it go below 200 by EOW?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/331365772005472","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":159,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":331534138331240,"gmtCreate":1721948660854,"gmtModify":1721948662841,"author":{"id":"3582794558746184","authorId":"3582794558746184","authorIdStr":"3582794558746184","name":"Ciboy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582794558746184"},"themes":[],"htmlText":"Great article, would you like to share it?","listText":"Great article, would you like to share it?","text":"Great article, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/331534138331240","repostId":"331398691086488","repostType":1,"repost":{"id":331398691086488,"gmtCreate":1721915434953,"gmtModify":1721977446441,"author":{"id":"4093561479903300","authorId":"4093561479903300","authorIdStr":"4093561479903300","name":"SPACE ROCKET","avatar":"https://community-static.tradeup.com/news/8d914d0fac29a13d969545b323fbfe8a","crmLevel":9,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4093561479903300"},"themes":[],"htmlText":"I opened <a href=\"https://ttm.financial/OPT/CLSK 20240802 18.5 CALL\">$CLSK 20240802 18.5 CALL$&nbsp;</a> ,Let's see how this goes. Wanted to sell 30 lots but Tiger has been crashing on me recently and not responding accurately to what I type. Kept registering 33 when I keyed in 30. So selling 33 it is!","listText":"I opened <a href=\"https://ttm.financial/OPT/CLSK 20240802 18.5 CALL\">$CLSK 20240802 18.5 CALL$&nbsp;</a> ,Let's see how this goes. Wanted to sell 30 lots but Tiger has been crashing on me recently and not responding accurately to what I type. Kept registering 33 when I keyed in 30. So selling 33 it is!","text":"I opened $CLSK 20240802 18.5 CALL$ ,Let's see how this goes. Wanted to sell 30 lots but Tiger has been crashing on me recently and not responding accurately to what I type. Kept registering 33 when I keyed in 30. So selling 33 it is!","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/331398691086488","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":48,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":331534055887072,"gmtCreate":1721948644797,"gmtModify":1721948648579,"author":{"id":"3582794558746184","authorId":"3582794558746184","authorIdStr":"3582794558746184","name":"Ciboy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582794558746184"},"themes":[],"htmlText":"Great article, would you like to share it?","listText":"Great article, would you like to share it?","text":"Great article, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/331534055887072","repostId":"331416561946720","repostType":1,"repost":{"id":331416561946720,"gmtCreate":1721920193370,"gmtModify":1721982707817,"author":{"id":"4093561479903300","authorId":"4093561479903300","authorIdStr":"4093561479903300","name":"SPACE ROCKET","avatar":"https://community-static.tradeup.com/news/8d914d0fac29a13d969545b323fbfe8a","crmLevel":9,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4093561479903300"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/CLSK\">$CleanSpark, Inc.(CLSK)$ </a>&nbsp;<a href=\"https://ttm.financial/S/MARA\">$Marathon Digital Holdings Inc(MARA)$ </a>&nbsp; My trades are not behaving because of this 😵‍💫😵‍💫🤯🤯 I ended up selling funny number of lots because of wonky Tiger that keeps crashing. Samsung keeps asking me to put Tiger Brokers to deep sleep! 😴 💤&nbsp;&nbsp;OMG&nbsp;🤦‍♀️🤦‍♀️ <a href=\"https://ttm.financial/U/4171900329979952\">@Barcode </a>&nbsp;<a href=\"https://ttm.financial/U/4142551860919612\">@nomadic_m </a>&nbsp;<a href=\"https://ttm.financial/U/4132300740238052\">@icycrystal </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/CLSK\">$CleanSpark, Inc.(CLSK)$ </a>&nbsp;<a href=\"https://ttm.financial/S/MARA\">$Marathon Digital Holdings Inc(MARA)$ </a>&nbsp; My trades are not behaving because of this 😵‍💫😵‍💫🤯🤯 I ended up selling funny number of lots because of wonky Tiger that keeps crashing. Samsung keeps asking me to put Tiger Brokers to deep sleep! 😴 💤&nbsp;&nbsp;OMG&nbsp;🤦‍♀️🤦‍♀️ <a href=\"https://ttm.financial/U/4171900329979952\">@Barcode </a>&nbsp;<a href=\"https://ttm.financial/U/4142551860919612\">@nomadic_m </a>&nbsp;<a href=\"https://ttm.financial/U/4132300740238052\">@icycrystal </a>&nbsp;","text":"$CleanSpark, Inc.(CLSK)$ $Marathon Digital Holdings Inc(MARA)$ My trades are not behaving because of this 😵‍💫😵‍💫🤯🤯 I ended up selling funny number of lots because of wonky Tiger that keeps crashing. Samsung keeps asking me to put Tiger Brokers to deep sleep! 😴 💤 OMG 🤦‍♀️🤦‍♀️ @Barcode @nomadic_m @icycrystal","images":[{"img":"https://community-static.tradeup.com/news/ed038a839300957d62869fb64c76e84a","width":"1440","height":"695"},{"img":"https://community-static.tradeup.com/news/af1f7492b9028567ec847cb80a851740","width":"1024","height":"1024"},{"img":"https://community-static.tradeup.com/news/feb091e9c1eb247badb3611373625d3f","width":"1024","height":"1024"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/331416561946720","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":3,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":98,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":838259531,"gmtCreate":1629415328623,"gmtModify":1676530031024,"author":{"id":"3582794558746184","authorId":"3582794558746184","authorIdStr":"3582794558746184","name":"Ciboy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582794558746184"},"themes":[],"htmlText":"The 3 Rs.","listText":"The 3 Rs.","text":"The 3 Rs.","images":[{"img":"https://static.tigerbbs.com/2b73a296bec84f92723b409fc422943f","width":"1440","height":"1835"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/838259531","isVote":1,"tweetType":1,"viewCount":151,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"lives":[]}